• The Cost of Drugs Today

    Forbes | A Forbes analysis finds that a company hoping to get a single drug to market can expect to have spent $350 million before the medicine is available for sale.

    Aug 12, 2013

  • Predicting Preterm Birth

    The Scientist | GNS Healthcare and Inova Translational Medicine Institute are collaborating to predict preterm birth. Using GNS's big data analytics platform and Invoa medical records, the groups hope to identify biomarkers that could predict early births.

    Aug 12, 2013

  • Big Data at the NIH

    CTOvision | Mark Guyer, deputy director of the NIH’s National Human Genome Research Institute (NHGRI), speaks with CTOvision about the big data centers of excellence, and the trends in data sharing.

    Aug 12, 2013

  • Gene By Gene to Acquire Arpeggi

    Bio-IT World | Arpeggi announced yesterday its impending acquisition by Gene By Gene, a Houston-based consumer genomics company that develops products for ancestry and genealogy applications. The new company hopes to make available an innovative suite of more affordable genetics testing and diagnostics services to consumers, researchers and healthcare providers.

    Aug 7, 2013

  • The Henrietta Compromise: NIH Announces HeLa Data Use Agreement

    Bio-IT World | The National Institutes of Health announced this morning that it has reached an “understanding” with the family of Henrietta Lacks to allow controlled access to whole genome sequence data from HeLa cells, the cells derived without consent from the tumor of Henrietta Lacks in 1951.

    Aug 7, 2013

  • Fast Science: Real Time Genomics Moves to Mendelian Diseases

    Bio-IT World | Real Time Genomics chose cows for their first proof of principle, but a lot has changed in the 18 months since I sat down in their Hamilton, New Zealand, offices and toured a dairy farmer’s cooperative down the road. Today RTG’s extremely fast genomics analytics platform is proving itself faster, cheaper and more efficient than the competition for tackling Mendelian genetics.

    Aug 6, 2013

  • 23andMe Launches TV Ads for DTC Genomics

    Bio-IT World News Brief | 23andMe has launched a television advertising campaign. Portraits of Health focuses on educating consumers about how understanding their DNA can help them make more informed and proactive health decisions, while building brand awareness for 23andMe.

    Aug 6, 2013

  • Combination Therapy Targets Breast Cancer that has Spread to Brain

    UCLA Newsroom | Using a mouse-model system, researchers at UCLA Jonsson Comprehensive Cancer Center have combined cellular therapy and gene therapy to develop a possible treatment for breast cancer that has spread to the brain.

    Aug 6, 2013

  • Kickstarting Cancer

    Forbes | What would crowd funding for cancer look like? A Forbes contributor suggests a Kickstarter campaign focusing on individuals with cancers that aren't responding to treatment or aren't well-characterized.

    Aug 5, 2013

  • Ceiba Launches Free Helium Analytical Workbench

    Bio-IT World News Brief | Ceiba has introduced a free version of its Helium Data Workbench that offers more than 50 analytical functions to bring public life science data directly into Microsoft Excel, TIBCO Spotfire and the Helium Windows 8 app.

    Aug 5, 2013

  • July News and Product Briefs

    Bio-IT World | News briefs and products from around the industry including Illumina's acquisitions, new products for clinical sites and data virtualization, Comcast in health-IT, and more.

    Aug 2, 2013

  • Biopharma Cubist Makes Two Acquisitions for up to $1.6B

    Bio-IT World News Brief |Cubist Pharmaceuticals, a Lexington, Mass.-based biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products that address significant unmet medical needs in the acute care environment has signed two merger agreements, with Trius Therapeutics and Optimer Pharmaceuticals. The combined total of the two acquisitions could $1.6 billion.

    Aug 2, 2013

  • Foundation Medicine's IPO Prospects

    Boston Globe | Foundation Medicine filed plans this week to raise $86.25 million in an IPO, and the Boston Globe posits it could be aiming too low.

    Aug 1, 2013

  • An Expert's Overview: the Genomics of Genius, Alzheimer's, and the Future of Hospitals

    Medspace | Eric Topol weighs in on what he's seen interesting on the Web lately including the genomics of genius, Alzheimer's Disease, and the obsolete future of the hospital room

    Jul 31, 2013

  • NVIDIA Acquires The Portland Group

    Bio-IT World News Brief | NVIDIA has acquired The Portland Group (PGI), a supplier of tools and compilers for high performance computing. "PGI and its exceptionally talented staff will continue to operate under the PGI flag – developing OpenACC, CUDA Fortran and CUDA x86 for multicore x86 and, of course, GPGPUs," NVIDIA said on its blog.

    Jul 30, 2013

  • Pfizer Transitions to D360 Drug Discovery Platform

    Bio-IT World | In 2010, Pfizer formed a partnership with Certara, an informatics company based in St. Louis, MO, to adopt Certara’s software system D360 as Pfizer’s core research platform. After a steady, months-long migration of users, Pfizer will complete its transition to D360 this year, replacing an internally-developed platform, RGate, in use since 2005. When the rollout is complete, D360 will be deployed to nearly 2,000 researchers across twelve global sites, making Pfizer the largest client to adopt D360 to date.

    Jul 29, 2013

  • New National Supercomputing Center Director

    News-Gazette | National Center for Supercomputing Applications will have a new director in January. Edward Seidel, a former post doc of Larry Smarr's.

    Jul 29, 2013

  • Biogen Idec's Open Space for Innovation

    Boston Globe | Biogen Idec is counting on the layout of its new Cambridge, Mass. building to foster conversations and collaboration. The new building opened last week and will have no offices and no cubicles, instead open work spaces, treadmill work stations, and "huddle rooms".

    Jul 29, 2013

  • Merck Finds Commercial Solution in Collaboration

    Bio-IT World | With a growing interest in biologics and a significant investment in deploying an electronic laboratory notebook (ELN) to thousands of employees, Merck decided in 2011 to partner with PerkinElmer to expand the functionality of the informatics provider’s E-Notebook ELN solution to meet the needs of its biologics workflows.

    Jul 25, 2013

  • Malaria Open Source Research Progress

    Guardian | In 2010, GlaxoSmithKline, the Genomics Institute of the Novartis Research Foundation and St Jude Children's Research Hospital in Memphis, Tenn., publicly released over 20,000 compounds active against malaria, launching open source research into the disease.

    Jul 25, 2013